Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.

Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.

Item
http://www.wikidata.org/entity/Q36675094
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In SilicoProton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General PopulationThe combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status.Self-reported history of childhood smoking is associated with an increased risk for peripheral arterial disease independent of lifetime smoking burden.High levels of serum β2-microglobulin predict severity of coronary artery diseaseAlternative ankle-brachial index method identifies additional at-risk individualsThe relationship between suicide and violence in schizophrenia: analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset.Role of β2-microglobulin in uremic patients may be greater than originally suspected.Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia.Clinical and socioeconomic factors associated with unrecognized peripheral artery disease.
P2860

Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.

Item
http://www.wikidata.org/entity/Q36675094
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Usefulness of the addition of ...... dergoing coronary angiography.
@ast
Usefulness of the addition of ...... dergoing coronary angiography.
@en
type
label
Usefulness of the addition of ...... dergoing coronary angiography.
@ast
Usefulness of the addition of ...... dergoing coronary angiography.
@en
prefLabel
Usefulness of the addition of ...... dergoing coronary angiography.
@ast
Usefulness of the addition of ...... dergoing coronary angiography.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Usefulness of the addition of ...... dergoing coronary angiography.
@en
P2093
P2860
P304
P31
P356
10.1016/J.AMJCARD.2012.11.055
P407
P433
P478
P577
P698
P932